[en] BACKGROUND: Hereditary angioedema (HAE) is a rare heritable disorder that is characterized by recurrent, circumscribed, nonpitting, nonpruritic, often painful subepithelial swellings of sudden unpredictable onset that generally fade during 48-72 h. Epidemiological data of hereditary angioedema patients in Belgium is lacking.
METHODS: We set up a nation-wide, multicentric study involving the 8 Belgian hospitals known to follow-up patients with Type I and II HAE. All Belgium HAE patients were asked to fill out questionnaires that mainly covered demographic data, family history, and detailed information about diagnosis, treatment and burden of their Type I and II HAE.
RESULTS: 112 patients with type I or type II HAE could be included. Median delay between first symptoms and diagnosis was 7 years. 51% of patients had experienced pharyngeal or tongue swelling and 78% had experienced abdominal symptoms, both known to cause an important reduction in quality of life. 60% of symptomatic patients reported to receive long term prophylactic treatment. Human plasma-derived C1-esterase inhibitor concentrate was used by 56.3% of patients. 16.7% and 27.1% of patients used a 17-α-alkylated androgen and tranexamic acid as long term prophylactic therapy.
CONCLUSIONS: We present the first nation-wide epidemiological study regarding HAE in Belgium. Our data show that the morbidity of HAE is not to be underestimated. Knowledge and dissemination of this data is critical in raising awareness, encouraging development of therapies and optimising nationwide management.
Disciplines :
Immunology & infectious disease
Author, co-author :
Van der Poorten, M M; Faculty of Medicine and Health Science, Department of Immunology - Allergology - Rheumatology, Antwerp University Hospital and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium ; Faculty of Medicine and Health Science, Department of Paediatrics, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium
Schrijvers, R; Faculty of Medicine, Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, KU Leuven, Leuven, Belgium
Hermans, C; Faculty of Medicine and Health Science, Department of Adult Haematology, Saint-Luc University Hospital, Brussels, Belgium
Bartiaux, M; Faculty of Medicine and Health Science, Department of Urgent Medicine, Hôpital Sient-Pierre, Brussels, Belgium
Haerynck, F; Faculty of Medicine and Health Science, Department of Internal Medicine and Paediatrics, Ghent University Hospital, Ghent, Belgium
Lapeere, H; Faculty of Medicine and Health Science, Department of Dermatology, Ghent University Hospital, Ghent, Belgium
Moutschen, Michel ; Centre Hospitalier Universitaire de Liège - CHU > > Service des maladies infectieuses - médecine interne
Michel, O; Faculty of Medicine, Department of Immunology and Allergology, C.H.U. Brugmann, Brussels, Belgium
Sabato, V; Faculty of Medicine and Health Science, Department of Immunology - Allergology - Rheumatology, Antwerp University Hospital and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium
Ebo, D G; Faculty of Medicine and Health Science, Department of Immunology - Allergology - Rheumatology, Antwerp University Hospital and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium
Van Gasse, A L; Faculty of Medicine and Health Science, Department of Immunology - Allergology - Rheumatology, Antwerp University Hospital and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium ; Faculty of Medicine and Health Science, Department of Paediatrics, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium
Language :
English
Title :
Hereditary angioedema (HAE) in Belgium: results from a national survey
Rik Schrijvers, Didier Ebo and Vito Sabato are supported by the Fonds Wetenschappelijk Onderzoek—Vlaanderen National Fund for Scientific Research (FWO) senior clinical investigator fellowship (Project numbers 1805518N, 1804518N and 1800614N respectively).
Longhurst H Cicardi M. Hereditary angio-oedema. Lancet. (2012) 379(9814):474–81. 10.1016/S0140-6736(11)60935-522305226
Maurer M Magerl M Betschel S Aberer W Ansotegui IJ Aygören-Pürsün E et al. The international WAO/EAACI guideline for the management of hereditary angioedema-the 2021 revision and update. Allergy. (2022) 77(7):1961–90. 10.1111/all.15214. Epub 2022 Feb 3. PMID: 35006617.35006617
Farkas H Martinez-Saguer I Bork K Bowen T Craig T Frank M et al. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Allergy. (2017) 72(2):300–13. 10.1111/all.1300127503784
Ebo DG Van Gasse AL Sabato V Bartholomeus E Reyniers E Vanbellinghen JF et al. Hereditary angioedema in 2 sisters due to paternal gonadal mosaicism. J Allergy Clin Immunol Pract. (2018) 6(1):277–279.e1. 10.1016/j.jaip.2017.07.00228888847
Ebo DG Blaumeiser B Kooy FR Beckers S Van Gasse AL Saerens M et al. Association of hereditary angioedema type 1 with developmental anomalies due to a large and unusual de novo pericentromeric rearrangement of chromosome 11 spanning the entire C1 inhibitor gene (SERPING1). J Allergy Clin Immunol Pract. (2019) 7(4):1352–1354.e3. 10.1016/j.jaip.2018.10.00530336291
Bork K Machnig T Wulff K Witzke G Prusty S Hardt J. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence. Orphanet J Rare Dis. (2020) 15(1):289. 10.1186/s13023-020-01570-x33059692
Sharma J Jindal AK Banday AZ Kaur A Rawat A Singh S et al. Pathophysiology of hereditary angioedema (HAE) beyond the SERPING1 gene. Clin Rev Allergy Immunol. (2021) 60(3):305–15. 10.1007/s12016-021-08835-833442779
Roche O Blanch A Caballero T Sastre N Callejo D López-Trascasa M et al. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol. (2005) 94(4):498–503. 10.1016/S1081-1206(10)61121-015875532
Johnsrud I Kulseth MA Rødningen OK Landrø L Helsing P Waage Nielsen E et al. A nationwide study of Norwegian patients with hereditary angioedema with C1 inhibitor deficiency identified six novel mutations in SERPING1. PLoS One. (2015) 10(7):e0131637. 10.1371/journal.pone.013163726154504
Bygum A. Hereditary angio-oedema in Denmark: a nationwide survey. Br J Dermatol. (2009) 161(5):1153–8. 10.1111/j.1365-2133.2009.09366.x19709101
Nordenfelt P Nilsson M Björkander J Mallbris L Lindfors A Wahlgren CF et al. Hereditary angioedema in Swedish adults: report from the national cohort. Acta Derm Venereol. (2016) 96(4):540–5. 10.2340/00015555-227426540175
Zanichelli A Arcoleo F Barca MP Borrelli P Bova M Cancian M et al. A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy. Orphanet J Rare Dis. (2015) 10:11. 10.1186/s13023-015-0233-x25758562
Psarros F Koutsostathis N Farmaki E Speletas MG Germenis AE. Hereditary angioedema in Greece: the first results of the Greek hereditary angioedema registry. Int Arch Allergy Immunol. (2014) 164(4):326–32. 10.1159/00036627625277223
Sobotkova M Zachova R Hakl R Kuklinek P Kralickova P Krcmova I et al. Acquired angioedema with C1 inhibitor deficiency: occurrence, clinical features, and management: a nationwide retrospective study in the Czech republic patients. Int Arch Allergy Immunol. (2021) 182(7):642–9. 10.1159/000512933
Gabos G Nadasan V Mihaly E Dobru D et al. Hereditary angioedema due to C1-inhibitor deficiency in Romania: first national study, diagnostic and treatment challenges. Iran J Immunol. (2020) 17(3):226–35. 10.22034/iji.2020.85416.1709. PMID: 32996899.32996899
Grivčeva-Panovska V Košnik M Korošec P Andrejević S Karadža-Lapić L Rijavec M et al. Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations and genetic factors modifying the clinical phenotype. Ann Med. (2018) 50(3):269–76. 10.1080/07853890.2018.1449959
Rijavec M Korošec P Šilar M Zidarn M Miljković J Košnik M et al. Hereditary angioedema nationwide study in Slovenia reveals four novel mutations in SERPING1 gene. PLoS One. (2013) 8(2):e56712. 10.1371/journal.pone.005671223437219
Guryanova I Suffritti C Parolin D Zanichelli A Ishchanka N Polyakova E et al. Hereditary angioedema due to C1 inhibitor deficiency in Belarus: epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene. Clin Mol Allergy. (2021) 19(1):3. 10.1186/s12948-021-00141-033827715
Bork K Anderson JT Caballero T Craig T Johnston DT Li HH et al. Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report. Allergy Asthma Clin Immunol. (2021) 17(1):40. 10.1186/s13223-021-00537-233875020
Lee EY Hsieh J Borici-Mazi R Caballero T Kanani A Lacuesta G et al. Quality of life in patients with hereditary angioedema in Canada. Ann Allergy Asthma Immunol. (2021) 126(4):394–400.e3. 10.1016/j.anai.2021.01.00233450396
